Does OSELTAMIVIR Cause Hepatic cytolysis? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Hepatic cytolysis have been filed in association with OSELTAMIVIR (oseltamavir phosphate). This represents 0.2% of all adverse event reports for OSELTAMIVIR.
27
Reports of Hepatic cytolysis with OSELTAMIVIR
0.2%
of all OSELTAMIVIR reports
1
Deaths
13
Hospitalizations
How Dangerous Is Hepatic cytolysis From OSELTAMIVIR?
Of the 27 reports, 1 (3.7%) resulted in death, 13 (48.1%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSELTAMIVIR. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does OSELTAMIVIR Cause?
Vomiting (1,561)
Off label use (1,538)
Nausea (1,055)
No adverse event (810)
Drug ineffective (688)
Dyspnoea (582)
Diarrhoea (553)
Hallucination (502)
Influenza (443)
Rash (439)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which OSELTAMIVIR Alternatives Have Lower Hepatic cytolysis Risk?
OSELTAMIVIR vs OSILODROSTAT
OSELTAMIVIR vs OSIMERTINIB
OSELTAMIVIR vs OSPEMIFENE
OSELTAMIVIR vs OSPHENA
OSELTAMIVIR vs OVINE DIGOXIN IMMUNE FAB